ChiCTR2100049356 版本V1.6 版本创建时间2022/04/18 09:03:52 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2100049356 

最近更新日期:

Date of Last Refreshed on:

2022-04-05 07:16:48 

注册时间:

Date of Registration:

2021-07-31 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

术前合并症对围术期骨外伤患者深静脉血栓的影响因素分析 ——基于病历记录的回顾性研究

Public title:

Analysis of the influencing factors of preoperative comorbidities on deep vein thrombosis in patients with perioperative bone trauma: a retrospective study based on medical records

注册题目简写:

English Acronym:

研究课题的正式科学名称:

术前合并症对围术期骨外伤患者深静脉血栓的影响因素分析

Scientific title:

Analysis of the influencing factors of preoperative comorbidities on deep vein thrombosis in patients with perioperative bone trauma

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张慧 

研究负责人:

程波 

Applicant:

Zhang Hui 

Study leader:

Cheng Bo 

申请注册联系人电话:

Applicant telephone:

+86 18883370176

研究负责人电话:

Study leader's
telephone:

+86 13983760123

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1150484566@qq.com

研究负责人电子邮件:

Study leader's E-mail:

7300703@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

重庆市渝中区友谊路1号

研究负责人通讯地址:

重庆市渝中区友谊路1号

Applicant address:

1 Youyi Road, Yuzhong District, Chongqing

Study leader's address:

1 Youyi Road, Yuzhong District, Chongqing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

400000

申请人所在单位:

重庆医科大学附属第一医院

Applicant's institution:

The First Affiliated Hospital of Chongqing Medical University

研究负责人所在单位:

重庆医科大学附属第一医院

Affiliation of the Leader:

The First Affiliated Hospital of Chongqing Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2019-235

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

重庆医科大学附属第一医院伦理委员会

Name of the ethic committee:

Ethics Committee of the First Affiliated Hospital of Chongqing Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2021-06-16 00:00:00

伦理委员会联系人:

重庆医科大学附属第一医院伦理委员会

Contact Name of the ethic committee:

Ethics Committee of the First Affiliated Hospital of Chongqing Medical University

伦理委员会联系地址:

重庆市渝中区友谊路1号

Contact Address of the ethic committee:

1 Youyi Road, Yuzhong District, Chongqing

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

重庆医科大学附属第一医院麻醉科

Primary sponsor:

Department of Anesthesia, the First Affiliated Hospital of Chongqing Medical University

研究实施负责(组长)单位地址:

重庆市渝中区友谊路1号

Primary sponsor's address:

1 Youyi Road, Yuzhong District, Chongqing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆

市(区县):

渝中区

Country:

China

Province:

Chongqing

City:

Yuzhong District

单位(医院):

重庆医科大学附属第一医院

具体地址:

友谊路1号

Institution
hospital:

The First Affiliated Hospital of Chongqing Medical University

Address:

1 Youyi Road

经费或物资来源:

自筹

Source(s) of funding:

Self-raised

研究疾病:

深静脉血栓形成  

Target disease:

Deep vein thrombosis

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

回顾性研究 

Study phase:

Retrospective study

研究设计:

析因分组(即根据危险因素或暴露因素分组) 

Study design:

Factorial 

研究目的:

通过相关研究,观察我院围术期血栓预防后骨创伤患者DVT的发生率;进一步探讨并验证围术期骨创伤患者术前合并症对下肢深静脉血栓的关系。为早期识别高危人群,有效预防下肢静脉血栓提供临床依据。  

Objectives of Study:

Through related research, observe the incidence of DVT in patients with bone trauma after perioperative thrombosis prevention in our hospital; further explore and verify the relationship between preoperative complications of perioperative bone trauma patients and deep vein thrombosis of the lower extremities. Provide clinical evidence for early identification of high-risk groups and effective prevention of lower extremity venous thrombosis.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.创伤性骨折;
2.髋部骨折(股骨颈、股骨转子间)、骨盆骨折、髋臼骨折、股骨远端骨折;
3.年龄>18岁;
4.临床病历资料完整。

Inclusion criteria

1.Traumatic fractures;
2.Hip fractures (femoral neck and intertrochanteric), pelvic fractures, acetabular fractures, and distal femoral fractures;
3.Aged > 18 years;
4.Complete clinical medical records.

排除标准:

1.合并血液系统疾病或凝血功能障碍;
2.长期服用抗凝药物史;
3.血管外科手术治疗史;
4.妊娠。

Exclusion criteria:

1.Complicated with blood system disease or coagulation dysfunction;
2.Long-term use of anticoagulant drugs;
3.History of vascular surgery;
4.Pregnancy.

研究实施时间:

Study execute time:

From 2021-07-01 00:00:00 To 2022-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-08-31 00:00:00 To 2022-02-28 00:00:00

干预措施:

Interventions:

组别:

术前非贫血组

样本量:

248

Group:

Preoperative non-anemia group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

术前贫血组

样本量:

321

Group:

Preoperative anemia group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆 

市(区县):

 

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆医科大学附属第一医院 

单位级别:

三级甲等 

Institution
hospital:

The First Affiliated Hospital of Chongqing Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

下肢静脉超声结果

指标类型:

主要指标

Outcome:

Lower extremity vein ultrasound results

Type:

Primary indicator

测量时间点:

住院期间

测量方法:

病历资料中静脉超声结果

Measure time point of outcome:

During hospitalization

Measure method:

Venous ultrasound results from medical records

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

不适用。

Randomization Procedure (please state who generates the random number sequence and by what method):

Not Applicable.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

N/A

Blinding:

N/A

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2023年6月;中国临床实验注册中心; http://www.chictr.org.cn/edit.aspx?pid=28637&htm=4。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

In June 2023; China clinical trials registry; http://www.chictr.org.cn/edit.aspx?pid=28637&htm=4.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Excel表格及SPSS软件。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Excel tables and SPSS software.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2021-08-01 06:12:14